(TheProudRepublic.com) – In a fresh move towards reforming the CDC, President Trump has nominated Dr. Susan Monarez as its next director to restore Americans’ lost confidence in an agency plagued by political bias and mismanagement.
See the tweet below.
The nomination comes as the former candidate, Dr. David Weldon, failed to secure enough Senate support.
Trump is betting on Monarez’s unique background to transform the troubled health agency that lost public trust during the pandemic.
Trump’s announcement highlighted Dr. Monarez’s impressive credentials, including her Ph.D. from the University of Wisconsin and postdoctoral training at Stanford University School of Medicine.
Unlike traditional CDC directors, Monarez is not a medical doctor but brings extensive experience in biomedical innovation and pandemic preparedness from her roles at the White House Office of Science and Technology Policy and the National Security Council.
President Trump did not mince words about the state of the agency Monarez will inherit, stating, “Americans have lost confidence in the CDC due to political bias and disastrous mismanagement.”
This direct acknowledgment of the agency’s failures under previous leadership signals Trump’s commitment to substantial reform at an institution that lost credibility with many Americans during COVID-19.
In addition, Dr. Monarez will work closely with Secretary of Health and Human Services Robert F. Kennedy Jr., forming a powerful team to take a fresh approach to addressing public health challenges.
Kennedy, a longtime critic of the pharmaceutical industry’s influence on health policy, and Monarez are expected to prioritize accountability and transparency – qualities sorely lacking during the pandemic response.
President Trump announced today he'll nominate Dr. Susan Monarez, acting CDC Director, to the top CDC job, following withdrawing his first pick's nomination, former Florida GOP Congressman Dr. Dave Weldon earlier this month right before his Senate confirmation hearing. https://t.co/UWdq5sLFsi pic.twitter.com/9NjiHSvCYL
— Craig Caplan (@CraigCaplan) March 24, 2025
The CDC faces immediate challenges, including responding to a measles outbreak and a bird flu situation, while simultaneously implementing major structural reforms.
Insiders reported that Monarez has been involved in decisions regarding significant workforce reductions at the CDC, which could potentially affect up to 30% of staff.
Monarez’s nomination marks a historic moment as she would become the first CDC director to undergo Senate confirmation, following a 2022 legislative change designed to increase accountability at the agency.
Senator Bill Cassidy (R-LA) has already formed a Senate Republican CDC working group, signaling strong congressional interest in reforming the agency that lost its way during the pandemic response.
Furthermore, Trump praised Monarez as someone who “brings decades of experience championing Innovation, Transparency, and strong Public Health Systems.”
The agency’s credibility crisis became evident when many Americans began questioning conflicting mask recommendations and other COVID-19 policies.
Critics are already questioning Monarez’s lack of medical credentials. Still, supporters point to her extensive homeland security and biomedical research background as excellent preparation for addressing America’s complex threats.
Her previous leadership at the Advanced Research Projects Agency for Health demonstrates her ability to drive innovation in medical research without being captured by establishment thinking.
With the CDC confirmation hearing expected in the coming weeks, Americans are hopeful that Monarez can restore an agency that lost its way during the pandemic through politicized guidance and ineffective leadership.
The nomination represents Trump’s commitment to placing qualified outsiders in positions where establishment thinking has failed the American people.
Copyright 2025, TheProudRepublic.com
